EcoDrugPlus

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSCGOG00000017256
Gene Symbol: SRD5A2
3 Cross references
192 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSCGOG00000000881
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSCGOG00000007706
Gene Symbol: LOC115017045
2 Cross references
194 Possible Orthologues:

Synaptic Vesicular Amine Transporter-Like

Ensembl ID : ENSCGOG00000017311
Gene Symbol: LOC115005129
3 Cross references
216 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSCGOG00000005683
Gene Symbol: TACR1
3 Cross references
214 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSCGOG00000016534
Gene Symbol: TACR2
3 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSCGOG00000000342
Gene Symbol: TACR3
3 Cross references
172 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSCGOG00000005368
Gene Symbol: TERT
3 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSCGOG00000016334
Gene Symbol: TBXAS1
3 Cross references
220 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSCGOG00000015832
Gene Symbol: TBXA2R
3 Cross references
193 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSCGOG00000006776
Gene Symbol: TYMS
3 Cross references
225 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSCGOG00000005560
Gene Symbol: THRB
3 Cross references
390 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).